CIK 0001811063 · Non-accelerated filer<br>Smaller reporting company
Nuvation Bio Inc.
Sign in to watch- Ticker
- NUVB
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 850862255
- Phone
- 332-208-6102
- Business address
- 1 PENNSYLVANIA PLAZA, SUITE 3805, NEW YORK, NY, 10019
- Former names
- Panacea Acquisition Corp
- 4 Open-market sale CHIEF SCIENTIFIC OFFICER sold 369,051 shares at $7.23 ($2,667,132)
- 4 Open-market sale CHIEF MEDICAL OFFICER sold 20,000 shares at $7.00 ($140,074)
- 4 Open-market sale CHIEF TECHNICAL OPERATIONS sold 200,000 shares at $7.14 ($1,427,680)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Open-market sale CHIEF MEDICAL OFFICER sold 30,000 shares at an average $4.93 ($148,028)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 8-K Event Regulation FD disclosure · Other events
- 144 Insider Sale of Securities
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Planned sale CHIEF SCIENTIFIC OFFICER sold 100,000 shares at $5.02 ($502,460)
- 144 Insider Sale of Securities
- 4 Derivatives Options or other derivatives
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 4 Open-market buy CHIEF PEOPLE OFFICER bought 10,000 shares at $1.71 ($17,100)
Page 4 of 20 · 400 filings